balance equationinconsistent2023-03-31
Withheld: assets, equity, liabilities could not be reconciled with the rest of this filer’s statement.
Revenue
$570.10M
Fiscal year ended 2026-06-30Operating income
$25.00M
Fiscal year ended 2026-06-30Free cash flow
Unavailable
Fiscal year ended 2026-06-30EDGEWELL PERSONAL CARE Co (EPC) reported revenue of $570.10M and net income of $13.70M for the fiscal year ended 2026-06-30. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from EDGEWELL PERSONAL CARE Co’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Perfumes, Cosmetics & Other Toilet Preparations.
Income
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $570.10M | $519.50M | $422.80M | $731.40M | $560.40M | $516.60M | $415.10M | $517.60M | $647.80M | $599.40M |
| Cost of revenue | $327.60M | $302.60M | $261.80M | $465.90M | $310.30M | $279.70M | $242.60M | $304.80M | $360.70M | $341.30M |
| Gross profit | $242.50M | $216.90M | $161.00M | $265.50M | $250.10M | $236.90M | $172.50M | $212.80M | $287.10M | $258.10M |
| Operating income | $25.00M | $18.40M | -$18.90M | -$6.60M | $45.00M | $49.00M | $9.30M | $20.40M | $82.70M | $70.10M |
| Net income | $13.70M | -$10.60M | -$65.70M | -$30.60M | $29.10M | $29.00M | -$2.10M | $8.80M | $49.00M | $36.00M |
| Research & development | $13.30M | $14.90M | $13.80M | $17.40M | $13.50M | $13.40M | $13.40M | $16.30M | $14.60M | $14.20M |
| Weighted-average diluted shares | shares 46.60M | shares 46.80M | shares 46.60M | Unavailable | shares 47.00M | shares 48.20M | shares 48.70M | Unavailable | shares 50.10M | shares 50.20M |
| Pretax income | $18.00M | $7.90M | -$36.90M | -$23.50M | $28.50M | $31.40M | -$12.70M | $5.40M | $62.50M | $47.00M |
| Income tax expense | $5.70M | $3.90M | -$7.70M | -$16.80M | $7.00M | $10.60M | -$2.60M | -$3.40M | $13.50M | $11.00M |
| Diluted EPS | $0.29 | $-0.22 | $-1.41 | Unavailable | $0.62 | $0.60 | $-0.04 | Unavailable | $0.98 | $0.72 |
| Selling, general & administrative | $108.30M | $111.00M | $102.40M | $121.90M | $100.70M | $102.80M | $99.60M | $109.20M | $110.10M | $107.50M |
| General & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | $209.10M | Unavailable | Unavailable |
| Total assets | $3.54B | $3.53B | $3.77B | $3.76B | $3.79B | $3.77B | $3.70B | $3.73B | $3.71B | $3.76B |
| Current assets | $1.11B | $1.11B | $1.06B | $995.50M | $1.00B | $1.01B | $945.20M | $936.00M | $958.70M | $994.80M |
| Total liabilities | $2.08B | $2.09B | $2.28B | $2.20B | $2.23B | $2.26B | $2.20B | $2.15B | $2.13B | $2.20B |
| Current liabilities | $603.60M | $613.80M | $497.50M | $565.50M | $567.40M | $536.30M | $459.00M | $563.60M | $535.10M | $541.90M |
| Total equity incl. NCI | $1.46B | $1.45B | $1.49B | $1.55B | $1.57B | $1.51B | $1.50B | $1.58B | $1.58B | $1.55B |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Inventory | $433.00M | $450.10M | $461.20M | $433.80M | $488.40M | $512.20M | $501.60M | $477.30M | $455.90M | $496.40M |
| Accounts receivable | $119.40M | $185.40M | $154.00M | $137.80M | $153.20M | $178.20M | $120.50M | $109.40M | $155.00M | $130.60M |
| Goodwill | $1.13B | $1.13B | $1.14B | $1.14B | $1.34B | $1.33B | $1.33B | $1.34B | $1.33B | $1.33B |
| Long-term debt | $1.24B | $1.24B | $1.52B | $1.38B | $1.37B | $1.43B | $1.44B | $1.28B | $1.29B | $1.35B |
| Accounts payable | $230.70M | $231.10M | $213.10M | $219.70M | $224.50M | $215.60M | $203.80M | $219.30M | $208.70M | $219.70M |
Cash flow
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $118.70M | $54.30M | -$125.90M | $74.10M | $114.80M | $45.10M | -$115.60M | -$388.30M | $101.20M | $129.00M |
| Capital expenditures | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Investing cash flow | -$14.10M | $325.00M | -$9.90M | -$27.60M | -$12.30M | -$17.30M | -$15.70M | -$25.50M | -$17.20M | -$13.70M |
| Financing cash flow | -$7.30M | -$300.80M | $133.40M | -$19.10M | -$83.40M | -$37.40M | $109.90M | -$40.10M | -$79.90M | -$129.20M |
| Net change in cash | $97.40M | $76.40M | -$2.40M | $26.10M | $29.50M | -$5.40M | -$33.60M | $13.00M | -$100.00K | -$18.00M |
| Stock-based compensation | $5.70M | $5.60M | $3.40M | $5.70M | $6.40M | $6.30M | $6.10M | $6.10M | $7.10M | $6.30M |
| Common dividends paid | $7.00M | $7.10M | $7.40M | $6.90M | $7.20M | $7.30M | $7.90M | $7.40M | $7.50M | $8.20M |
| Common share repurchases | $0 | $15.80M | $0 | $0 | $24.50M | $35.40M | $30.30M | $18.30M | $9.90M | $15.30M |
| Depreciation & amortization | $18.60M | $19.10M | $21.30M | $23.20M | $22.10M | $21.80M | $21.70M | $21.40M | $21.70M | $22.40M |
Derived
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Gross margin | 42.5% | 41.8% | 38.1% | 36.3% | 44.6% | 45.9% | 41.6% | 41.1% | 44.3% | 43.1% |
| Operating margin | 4.4% | 3.5% | -4.5% | -0.9% | 8.0% | 9.5% | 2.2% | 3.9% | 12.8% | 11.7% |
| FCF margin | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| SBC / revenue | 1.0% | 1.1% | 0.8% | 0.8% | 1.1% | 1.2% | 1.5% | 1.2% | 1.1% | 1.1% |
| Current ratio | 1.84x | 1.81x | 2.12x | 1.76x | 1.77x | 1.89x | 2.06x | 1.66x | 1.79x | 1.84x |
| Revenue YoY growth | 1.7% | 0.6% | 1.9% | 41.3% | -13.5% | -13.8% | -15.1% | -3.1% | -0.3% | Unavailable |
| Net margin | 2.4% | Unavailable | Unavailable | -4.2% | 5.2% | Unavailable | Unavailable | 1.7% | 7.6% | Unavailable |
| R&D / revenue | 2.3% | 2.9% | 3.3% | 2.4% | 2.4% | 2.6% | 3.2% | 3.1% | 2.3% | 2.4% |
| CapEx / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Long-term debt / equity | 0.85x | Unavailable | Unavailable | 0.89x | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | 31.7% | 49.4% | Unavailable | Unavailable | 24.6% | 33.8% | Unavailable | -63.0% | 21.6% | 23.4% |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open EPC in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-08-05View SEC filing
10-Q · Filed 2026-05-06View SEC filing
10-Q · Filed 2026-02-09View SEC filing
10-K · Filed 2025-11-18View SEC filing
10-Q · Filed 2025-08-05View SEC filing
10-Q · Filed 2025-05-07View SEC filing
Reconciliation checks needing review
6 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.
gross profit bridgeinconsistent2023-03-31
Withheld: cost revenue, revenue could not be reconciled with the rest of this filer’s statement.
cash flow reconciliationreview2024-09-30
Operating, investing and financing flows differ from the reported change in cash by 462000000, beyond tolerance 3883000.00.
cash flow reconciliationreview2023-09-30
Operating, investing and financing flows differ from the reported change in cash by 432200000, beyond tolerance 3844000.00.
balance equationreview2023-06-30
Difference 8800000 exceeds tolerance 3766300.000. Presentation or filing-vintage differences need review.
balance equationreview2022-12-31
Difference 7900000 exceeds tolerance 3797000.000. Presentation or filing-vintage differences need review.